QNRX — Quoin Pharmaceuticals, Ltd.

Healthcare • Biotechnology

$12.10

▼ -4.07 (—%)

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Insider Activity Congress Trades Company Site ↗

Company

Ticker: QNRX
Exchange
Sector: Healthcare
Industry: Biotechnology
Country: US
CEO: Michael Myers
Employees: 3
Website: quoinpharma.com

Price

3M 1Y 5Y ALL

Showing 1Y history. Source: FMP “historical price full”.

Prev Close: $16.17
Day High: $16.17
Day Low: $12.00
52w High: $48.30
52w Low: $5.01
Volume: 116,083
Avg Volume
Beta: 1.864

Key Metrics

Market Cap: 7.12M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available